Prosecution Insights
Last updated: October 02, 2026

Examiner: REYES, REGINALD R

Tech Center 3600 • Art Units: 3626 3684 3686

This examiner grants 41% of resolved cases

Analysis

Reginald R. Reyes is an examiner in Tech Center 3600, specifically Art Unit 3626, with 616 resolved cases. His allowance rate of 40.9% suggests a challenging environment where a majority of the applications do not result in a grant. This baseline rate indicates that practitioners should expect a rigorous examination process and be prepared to address significant objections during prosecution.

The median days to allowance is 1593, which reflects a long timeline for those applications that are eventually allowed. However, the data also shows a significant interview lift of 31.9%. This metric suggests that the probability of success increases substantially when an interview is held, providing a clear path to improve the 40.9% baseline and potentially resolve issues that are stalling the application.

For the 616 resolved cases, the 31.9% interview lift is a key strategic tool. The 1593-day median duration highlights the importance of early and effective intervention. Practitioners should use interviews as a primary method for navigating Art Unit 3626, as the data suggests this examiner is responsive to direct communication, which can help overcome the initial low probability of allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

41.0%
Allow Rate
-11.0% vs TC avg
657
Total Applications
+31.9%
Interview Lift
1590
Avg Prosecution Days
Based on 617 resolved cases, 2023–2026

Rejection Statute Breakdown

41.5%
§101 Eligibility
7.4%
§102 Novelty
33.2%
§103 Obviousness
11.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18925827 USER INTERFACES FOR TRACKING MEDICATIONS Non-Final OA Apple Inc.
17811072 INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM Final Rejection FUJIFILM CORPORATION
19216011 CAREGIVER ASSISTANCE SYSTEM Non-Final OA Stryker Corporation
19216015 CAREGIVER ASSISTANCE SYSTEM Non-Final OA Stryker Corporation
16650501 METHOD FOR ANALYSING A MEDICAL IMAGING DATA SET, SYSTEM FOR ANALYSING A MEDICAL IMAGING DATA SET, COMPUTER PROGRAM PRODUCT AND A COMPUTER-READABLE MEDIUM Non-Final OA Siemens Healthcare GmbH
18968898 SYSTEMS AND METHODS FOR DISEASE RISK PREDICTION FOR HIGH-RISK PATIENTS USING HIGHEST-K LOSS OPTIMIZED MACHINE LEARNING Non-Final OA REGENTS OF THE UNIVERSITY OF MICHIGAN
19009253 ADVERSE DRUG DETECTION USING ONTOLOGY-AUGMENTED LARGE LANGUAGE MODELS Final Rejection Oracle International Corporation
19032053 OCCUPATIONAL STRESS MANAGEMENT USING DIGITAL HUMANS AND HUMAN-COMPUTER INTERACTIONS Final Rejection International Business Machines Corporation
17032080 METHODS, SYSTEMS, AND DEVICES FOR GENERATING A REFRESHMENT INSTRUCTION SET BASED ON INDIVIDUAL PREFERENCES Non-Final OA KPN INNOVATIONS, LLC.
19047245 METHOD FOR SAMPLE TEST COUNTING Non-Final OA SYSMEX CORPORATION
18162157 METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR DISCOVERING PATIENT BENEFITS UNDER A HEALTH CARE COVERAGE PLAN Final Rejection Optum, Inc.
17771382 ACCELERATED EVOLUTION AND RESTRUCTURING TECHNIQUES FOR DEVELOPING EVOLVED STRUCTURES Final Rejection UNM RAINFOREST INNOVATIONS
17823915 DATA REPOSITORY, SYSTEM, AND METHOD FOR COHORT SELECTION Non-Final OA GUARDANT HEALTH, INC.
19214265 PRESCRIPTION ASSISTANCE DEVICE AND PRESCRIPTION ASSISTANCE METHOD Non-Final OA TERUMO KABUSHIKI KAISHA
16806786 SYSTEM, METHOD COMPUTER PROGRAM PRODUCT AND APPARATUS FOR DYNAMIC PREDICTIVE MONITORING IN THE CRITICAL HEALTH ASSESSMENT AND OUTCOMES STUDY (CHAOS) Non-Final OA University Of Cincinnati
19009409 MACHINE LEARNING MODELS FOR ADDISON'S DISEASE RISK ANALYSIS Final Rejection IDEXX Laboratories, Inc.
17968766 COVARIATE CORRECTION INCLUDING DRUG USE FROM TEMPORAL DATA Final Rejection ILLUMINA, INC.
18971064 SYSTEM AND METHOD OF INTEGRATION OF IN-PERSON AND IN-CLINIC SERVICE ENGINE PLATFORM WITH AN EMR SYSTEM Final Rejection Teledact Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month